| scholarly article | Q13442814 |
| P356 | DOI | 10.1021/JM3007323 |
| P698 | PubMed publication ID | 22784008 |
| P50 | author | Christian Laggner | Q114451963 |
| Javier Burgueno | Q114780783 | ||
| Daniel Zamanillo | Q122981817 | ||
| P2093 | author name string | Manuel Merlos | |
| José Luis Díaz | |||
| José Miguel Vela | |||
| Adriana Port | |||
| Ariadna Fernández | |||
| Carmen Almansa | |||
| Helmut Buschmann | |||
| Joana Berrocal | |||
| Jörg Holenz | |||
| Maria Teresa Serafini | |||
| Montserrat Contijoch | |||
| Rosa Cuberes | |||
| Ute Christmann | |||
| P433 | issue | 19 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 8211-8224 | |
| P577 | publication date | 2012-07-27 | |
| P1433 | published in | Journal of Medicinal Chemistry | Q900316 |
| P1476 | title | Synthesis and biological evaluation of the 1-arylpyrazole class of σ(1) receptor antagonists: identification of 4-{2-[5-methyl-1-(naphthalen-2-yl)-1H-pyrazol-3-yloxy]ethyl}morpholine (S1RA, E-52862). | |
| P478 | volume | 55 |
| Q64922722 | A New Pharmacophore Model for the Design of Sigma-1 Ligands Validated on a Large Experimental Dataset. |
| Q30400072 | A Review of the Human Sigma-1 Receptor Structure |
| Q91031402 | A SARS-CoV-2-Human Protein-Protein Interaction Map Reveals Drug Targets and Potential Drug-Repurposing |
| Q51420967 | A systematic exploration of the effects of flexibility and basicity on sigma (σ) receptor binding in a series of substituted diamines. |
| Q92572737 | Discovery of a novel class of potent and selective tetrahydroindazole-based sigma-1 receptor ligands |
| Q52996667 | Effects of centrally acting analgesics on spinal segmental reflexes and wind-up. |
| Q48258075 | Fluorinated PET Tracers for Molecular Imaging of σ1 Receptors in the Central Nervous System |
| Q38513640 | Investigational sigma-1 receptor antagonists for the treatment of pain. |
| Q38723014 | Medicinal Chemistry of σ1 Receptor Ligands: Pharmacophore Models, Synthesis, Structure Affinity Relationships, and Pharmacological Applications |
| Q89525831 | Morpholine As a Scaffold in Medicinal Chemistry: An Update on Synthetic Strategies |
| Q52478636 | New consensus multivariate models based on PLS and ANN studies of sigma-1 receptor antagonists. |
| Q47353437 | Novel Sigma-1 receptor antagonists: from opioids to small molecules: what is new? |
| Q38896666 | Pharmacological Modulation of the Sigma 1 Receptor and the Treatment of Pain |
| Q38235503 | Selective sigma-1 receptor antagonists for the treatment of pain. |
| Q39153819 | Sigma 2 Receptor/Tmem97 Agonists Produce Long Lasting Antineuropathic Pain Effects in Mice |
| Q37439130 | Sigma-1 Receptor Agonism Promotes Mechanical Allodynia After Priming the Nociceptive System with Capsaicin |
| Q39158236 | Sigma-1 Receptor Antagonists: A New Class of Neuromodulatory Analgesics |
| Q53647635 | Sigma-1 Receptor and Pain. |
| Q87462009 | Sigma-1 receptor inhibition reverses acute inflammatory hyperalgesia in mice: role of peripheral sigma-1 receptors |
| Q55437025 | Sigma-1 receptor: a new player in neuroprotection against chemotherapy-induced peripheral neuropathy. |
| Q34670217 | Sigma-1 receptors and animal studies centered on pain and analgesia |
| Q48142973 | Solid-phase organic synthesis of chiral, non-racemic 1,2,4-trisubstituted 1,4-diazepanes with high σ1 receptor affinity. |
| Q47756273 | Structure-Activity Relationships within a Series of σ1 and σ2 Receptor Ligands: Identification of a σ2 Receptor Agonist (BS148) with Selective Toxicity against Metastatic Melanoma. |
| Q64093881 | Supraspinal and Peripheral, but Not Intrathecal, σR Blockade by S1RA Enhances Morphine Antinociception |
| Q46466603 | Synthesis and pharmacological evaluation of like- and unlike-configured tetrahydro-2-benzazepines with the α-substituted benzyl moiety in the 5-position |
| Q51076938 | Synthesis, σ receptor affinity, and pharmacological evaluation of 5-phenylsulfanyl- and 5-benzyl-substituted tetrahydro-2-benzazepines. |
| Q38639528 | The Sigma-1 Receptor Antagonist, S1RA, Reduces Stroke Damage, Ameliorates Post-Stroke Neurological Deficits and Suppresses the Overexpression of MMP-9. |
| Q51750311 | The calcium-sensitive Sigma-1 receptor prevents cannabinoids from provoking glutamate NMDA receptor hypofunction: implications in antinociception and psychotic diseases. |
Search more.